HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The clinical presentation and management of carcinoid heart disease.

Abstract
Carcinoid heart disease is a major cause of morbidity and mortality in patients with metastatic neuroendocrine tumours (NETs). Although cases of carcinoid syndrome and severe carcinoid heart disease requiring urgent intervention are well described, many patients with significant carcinoid heart disease may have insidious symptoms or even be asymptomatic. As haemodynamically significant carcinoid heart disease may be clinically silent, specific and individualised considerations must be made as to the most appropriate clinical criteria and time point at which surgical valve replacement should be undertaken in patients with carcinoid heart disease.
AuthorsR Dobson, M I Burgess, D M Pritchard, D J Cuthbertson
JournalInternational journal of cardiology (Int J Cardiol) Vol. 173 Issue 1 Pg. 29-32 (Apr 15 2014) ISSN: 1874-1754 [Electronic] Netherlands
PMID24636550 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
CopyrightCopyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Topics
  • Carcinoid Heart Disease (diagnostic imaging, mortality, therapy)
  • Disease Management
  • Heart Valve Prosthesis Implantation (mortality)
  • Humans
  • Observational Studies as Topic (mortality)
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: